Dual strategy for inhibiting the infectious cycle of SARS-CoV­2 – Project Progress

This project is carried out in collaboration with Dr. Maria Waldhoer (InterAx Biotech). We thank BIOCAT for funding.

Stage 1

Target modeling

Dynamics of virus attachment.

Stage 3

Proof of concept

Drug candidates are currently tested in cell-based assays. Three promising candidates have been identified.

Stage 2

Drug-reprofiling

First hits obtained!

Stage 4

Preparation of clinical trial application

---